Alternanthera tenella Colla extracts are used in Brazilian traditional folk medicine to treat a variety of infectious diseases as well as inflammation and fever. In this work, the immunomodulatory, anti-inflammatory and potential toxic effects of cold (CAE) and hot (HAE) aqueous extracts of
Utilization of natural products with therapeutic properties is as old as human civilization. For a long period of time, minerals, plants and animal products were the main sources of drugs with different properties (De Pasquale 1984) . Today, many natural plant products and synthetic compounds have been evaluated for their capacity to modulate immune responses (Davis & Kuttan 2000 , Bin-Hafeez et al. 2003 , Barnes et al. 2005 , Cheng et al. 2005 , Patwardhan & Manish 2005 . The immunomodulatory potential of Alternanthera maritima extracts and isolated flavonoids were recently investigated by our research group and it was observed that they have stimulatory activity in the humoral immune system (Uecker et al. 2003) . Alternanthera, a genus belonging to the Amaranthaceae family, contains 80 species, 30 of which occur in Brazil (Siqueira & Guimarães 1984) . This family shows great chemical diversity in its constituents (steroids, flavonoids, alkaloids, saponins and terpenes) (Patterson et al. 1991 , Salvador & Dias 2004 , but Amaranthaceae is a Brazilian flora component that has not been significantly explored. Other species evaluated have shown antitumoral (Gomphrena martiana) (Pomilio et al. 1994) , analgesic (Alternanthera brasiliana) (Macedo et al. 1999 ) and antiviral (HIV -Alternanthera philoxeroides) (Zhang et al. 1988) activities. Alternanthera tenella Colla, a herbaceous plant commonly known as "enxuga" or "perpétua do mato," is frequently found in northwest Brazil (Guerra et al. 2003) , but also occurs in other regions, like the state of São Paulo (Salvador 2005) . It is used in popular medicine to treat fever, infection and inflammation (Rego 1995) . Other biological activities including antibacterial (Salvador 2005) and antifungal ) activity, as well as viability reduction of Trypanosoma cruzi trypomastigotes and Leishmania amazonensis amastigotes (Salvador 2005) have recently been reported. Moreover, phytochemical analysis of the antioxidant ethanolic extract of A. tenella has also been documented and led to the isolation of six major antioxidant flavonoid constituents (Salvador et al. 2006 ).
The immunomodulatory and anti-inflammatory activities of A. tenella were evaluated in this study based upon its utilization in popular medicine and the biological activities it has already demonstrated. Plant aqueous extracts were evaluated in the context of the BALB/c mice immune system by determining its effects on body and lymphoid organ weights, splenic cellularity, plaqueforming cells (PFC), antibody production (ELISA) and carrageenan-induced paw edema. (Fig. 1) . The lyophilized extracts were dissolved in pyrogenfree isotonic saline, sterilized using a Millipore filter (0.2 µm) and stored at 4 o C.
MATERIALS AND METHODS

Plant material and crude extract preparation -
Phytochemical screening of the aqueous crude extracts -Phytochemical screening of the extract was carried out using a conventional protocol (Wagner et al. 1984) for detecting the presence of different constituents like tannins, saponins, unsaturated sterols, triterpenoids, alkaloids and flavonoids. Common precipitation and coloring reagents were used to screen the CAE and HAE for phenolic compounds (FeCl 3 , 2%) and alkaloids (Dragendorff and Mayer reagents). The extracts were monitored by TLC chromatography (20 x 20 cm glass plates, 0.25 mm thick, Si gel GF 254 , Merck, Brazil), eluted with nBuOH/AcOH/H 2 O (BAW) 65:15:25, and then revealed with chromogenic spray reagents (phosphomolybdic acid 20% in MeOH w/v and p-anisaldehyde 0.5% in H 2 SO 4 w/v, followed by heating at 110 o C and NP/PEG) and exposed to NH3 vapor and UV light at 254 and 366 nm (Wagner & Bladt 1996) . IR spectra (KBr pellets) were recorded using a Nicolet Protégé 460 spectrometer. 1H NMR spectra were run with D 2 O on a Brucker Advance DPX 300 (3300 MHz) spectrometer. Treatment of mice for PFC and cellularity assaysMice were separated into experimental groups (n = 6). Positive control and treated groups were retroorbitally immunized with sheep red blood cells (SRBC) (0.1 mL, 25% suspension in saline) and concomitantly inoculated intraperitoneally (i.p.) with 0.2 mL sterile saline (positive control group) or 0.2 mL of CAE or HAE extracts containing 50, 100 or 200 mg/Kg body weight in a single administration (treated groups). Negative controls received only 0.2 mL sterile saline (i.p.).
Animals -
Body and lymphoid organ weights -Mouse body weights were obtained at the time of immunization (day 0) and 4, 7 and 14 days after the single treatment with extracts. Organ weights for the spleen, liver and thymus were determined for each animal after sacrifice by cervical dislocation four or 14 days from start of treatment according to the experiment.
Splenic cellularity -Mouse spleens for cell counting were prepared in Hank's balanced salt solution (HBSS). Four days after immunization with SRBC and administration of different treatments (as described above), the spleen was teased apart, the cells treated with 3 mL of erythrocyte lysis buffer (0.16 M NH 4 Cl; 0.17 M Tris; pH 7.65), washed three times and suspended in HBSS. The Neubauer chamber was used for cell counting and viability was determined by the Trypan Blue exclusion test.
PFC -Four days after immunization with SRBC and different treatments in mice, the PFC assay was performed using spleen cells according to the method of Jerne and Nordin (1963) . Spleen cells collected from individual animals (0.1 mL; 1 x 10 6 cells/0.1 mL), 0.4 mL of 0.5% "low melting point" agarose (GIBCO, Grand Island, NY, USA) in HBSS, and 50 µL of a suspension of 5% SRBC were added to test tubes at 37ºC and poured onto microscope slides containing a bottom layer of 0.5% agarose in water. The slides were then incubated for 2 h at 37ºC and 5% CO 2 . Guinea pig serum diluted 1:4 in HBSS was added to the slides and after another 40 min (37ºC and 5% CO 2 ) incubation the number of plaques was counted and values were expressed as PFC per 10 6 cells. For the preparation of guinea pig serum as the complement source, animals were anesthetized before cardiac puncture and blood samples were collected. Serum was obtained and previously absorbed with SRBC before being stored at -70 o C.
Preparation of SRBC membrane antigens -Partially purified SRBC membrane antigens were prepared as described by Temple et al. (1993) with some modifica- tions. All procedures were carried out at 4ºC. Briefly, sheep blood was collected in Alsever's solution and cells were isolated by centrifugation at 1,000 g for 15 min. After removal of plasma and the buffy coat, the cells were washed with five volumes of 0.9% NaCl three times. The washed pellets were suspended in approximately two volumes of 0.05 M Tris-HCl with 0.1 mM EDTA (pH 7.6), were mixed thoroughly and were centrifuged at 25,000 g for 30 min. This process was repeated as necessary until the supernatant became clear. The pellet suspension was further filtered through three layers of gauze, centrifuged again and resuspended in 0.1% sodium dodecyl sulfate (SDS) with 0.02% sodium azide (three times pellet volume). The solubilized membrane antigens were dialyzed against 0.1% SDS in PBS (molecular weight cut-off 12-14 kDa) and stored at -20ºC. Total protein quantification was performed as described previously using the Bradford (1976) assay.
Enzyme-linked immunosorbent assay (ELISA) -
Anti-SRBC circulating antibody titers of mice were determined by ELISA. SRBC antigen, in aliquots of a 5 µg/mL suspension in PBS, pH 7.2 (125 µL/well), was incubated overnight at 4ºC in high-binding microplates (Costar, New York, USA). Prior to each subsequent step, plates were washed three times with PBS-T (0.05% Tween 20, Sigma-Aldrich, St Louis, MO, in PBS). Unbound sites were blocked with 3% powdered milk in PBS (200 µL/well) for 2 h at room temperature (RT). Serum from experimental animals diluted 1:8 in PBS-T was added to the wells (125 µL/well) followed, after 1 h incubation at RT, by horseradish peroxidase conjugated anti-mouse IgG (1:1000) and IgM (1:2000) (Caltag Laboratories Inc, Burlingame, CA) diluted in PBS-T (125 µL/well). After another hour at RT, OPD substrate (Sigma Fast TM OPD, Sigma-Aldrich, St Louis, MO) was added (200 µL/well) and the plates were incubated in the dark for 20 min at RT. The reaction was stopped with 2 M H 2 SO 4 (75 µL/well) and the color in each well was evaluated at 490 nm on an ELISA reader (Spectramax Plus, Molecular Devices, Sunnyvale, CA), Softmax program.
Carrageenan-induced edema -Mice were treated i.p. with 0.2 mL of the aqueous extracts (CAE or HAE), 200 or 400 mg/kg or indomethacin (5 mg/kg) or sterile saline (control). After 60 min, edema was induced with an injection of 50 µL of 1% carrageenan in saline into the right hind paw. Paw thicknesses were measured using a dial caliper (Mitutoyo, Japan) immediately prior to carrageenan injection, 30 min after, and then at hourly intervals up to 5 h afterwards. Data are shown as increases in paw thickness and the difference between treated animals and controls was evaluated at the same time point after carrageenan injection. For this assay, mice were separated into six groups: (a) controls receiving the vehicle, saline, n = 5; (b) CAE extract (receiving 200 mg/ kg or 400 mg/kg, n = 6); (c) HAE extract (receiving 200 mg/kg, n = 5 or 400 mg/kg, n = 6); (d) indomethacin (receiving 5 mg/kg, n = 6).
Statistical analysis -The results were expressed as means ± SEM and were evaluated by one-way analysis of variance (ANOVA), followed by the Tukey test for multiple comparisons of body weights, lymphoid organ weights, splenic cellularity evaluation, PFC and ELISA assays. Results of the carrageenan-induced edema assay (CIEA) were expressed as means ± SD and evaluated by two-way ANOVA, followed by the Bonferroni test for multiple comparisons. Levels of significance were set at p < 0.05.
RESULTS
Phytochemical screening -The phytochemical screening of the aqueous extracts using common precipitation and coloring reagents revealed the possible presence of flavonoids, tannins, glycosides and saponins. Tests for steroids, alkaloids, lactones/ester and protein/amino acids were found to be negative. Spectrometric (IR and NMR) and chromatographic (TLC) analyses of CAE and HAE suggested that flavonoids glycosides and saponins are among the main constituents that can be related with the biological activity of the extracts. The IR spectrum showed absorptions of OH groups (3350 cm H-NMR spectrum (Hostettmann et al. 1991 , Markham & Geiger 1994 . Sesquiterpene lactones were not detected since typical carbonyl bands of α,β-unsaturated-γ-lactones were not observed in the IR spectrum between 1750-1780 cm -1 , while typical olefinic protons did not appear in the NMR spectra. The results of the phytochemical analysis are shown in Table I . The number of positive signs indicated the intensity of the reactions that reflect the quantity present.
Effect of CAE and HAE extracts on body and lymphoid organ weights -Mice treated once with CAE or HAE extracts in doses of 50, 100 or 200 mg/kg did not show significant differences in body and lymphoid organ weights after 4, 7 and 14 days when compared to controls ( Tables II, III) . Body weights are expressed in absolute values and relative organ weights as organ weight (mg)/ body weight (g). Another groups of mice treated i.p. with CAE or HAE extracts in doses of 200 or 400 mg/ kg (CIEA) also did not demonstrate an organ weight decrease (Table IV) . However, mice treated with CAE 400 mg/kg displayed a liver weight increase of 19.5%.
Effect of CAE or HAE extracts on spleen cellularity -Spleen cellularity data did not indicate significant increases in treated mice at any of the doses (Fig. 2) when compared to the positive control group (animals immunized with SRBC). The positive control groups showed an increase in cellularity (p < 0.01 -CAE; p < 0.001 -HAE) when compared with negative controls (saline), demonstrating immunization efficiency. Cell viability was approximately 90%-88% in CAE or HAE-treated mice, respectively.
Effect of CAE or HAE extracts in the PFC assay -
The effect of CAE or HAE extracts on PFC production is shown in Fig. 3 . Mice treated with CAE 100 mg/kg showed a significant increase (p < 0.05) when compared to the control groups (Fig. 3A) . However, no significant effect was seen in animals treated with CAE 50 and 200 mg/ kg. Treatment with HAE at all doses did not induce significant increases in PFC numbers, but a dose-dependent increased tendency in PFC production was observed and shown in Fig. 3B . ters increased in immunized and CAE-treated mice as shown in Fig. 4 . A significant IgM titer increase was observed for doses 50, 100 and 200 mg/kg (p < 0.05, p < 0.01 and p < 0.01, respectively - Fig. 4B ) in comparison to the positive control, four days after immunization and treatment. The increase was also observed in animals immunized and treated with 50 mg/kg (p < 0.05) compared to positive controls seven days after treatment (Fig. 4C) . IgG titers also increased significantly in mice treated with three doses of CAE 50, 100 and 200 mg/kg (p < 0.01, p < 0.05 and p < 0.05, respectively) after seven days (Fig. 4C ) when compared with immunized-only mice (positive control). A similar profile was obtained after 14 days, but the differences were not significant (Fig. 4D) . No significant effect in antibody titers was observed after treatments with HAE extracts in immunized animals for any of the doses or periods evaluated (Fig. 5) . Fig. 6 shows that injection of carrageenan in the control group induced acute inflammation with a prominent increase in paw thickness, beginning 1 h after intraplantar injection and reaching a peak of inflammation after 3 and 4 h. i.p. administration of CAE at 200 or 400 mg/kg, 1 h before the carrageenan injection, induced dose-dependent edema inhibition. CAE 200 mg/ kg, induced 42% inhibition (p < 0.01) after the first hour and 50% (p < 0.001) after 3 h. A higher dosage of the extract (400 mg/kg) inhibited the edema by 61% and 60% (p < 0,001) after three and four hours, respectively (Fig.  6A) , an effect that was even higher than that of indomethacin (5 mg/kg), the anti-inflammatory drug used in the positive control. Indomethacin reduced the edema by a maximum of 55% (p < 0.001) after 3 h. HAE extracts at a dose of 200 mg/kg, inhibited edema by 40% (p < 0 .01) only at the first hour. More effectively, HAE 400 mg/kg inhibited edema 2 h after carrageenan administration, reaching a maximum of 56% (p < 0.001) at 3 h (Fig. 6B) .
Effect of CAE or HAE extracts on circulating antibody titers -SRBC membrane antigen was prepared as described in Material and
Effect of CAE and HAE extracts on carrageenan-induced edema -
DISCUSSION
The therapeutic potential of several plant species and the necessity for scientific validation of the use of plants in popular medicine have prompted increased interest in the field. A large number of plant species and their components have been shown to be potential immunomodulators acting as anti-inflammatory, antistress and anticancer agents (Bin-Hafeez et al. 2003) . In this study, we investigated the immunomodulatory/immunotoxic and anti-inflammatory effects of aqueous extracts of A. tenella obtained in different conditions. The results suggest that A. tenella contains immunomodulators, in accordance with previous studies (Moraes et al. 1994 , Silveira 2000 , Guerra et al. 2003 .
After four and 14 days of i.p. administration, extracts CAE and HAE did not alter spleen weights in mice at the concentrations evaluated. A decrease in spleen weight would be indicative of immunotoxicity (Doi et al. 1996) . Other organs like the liver and thymus, also involved in toxic conditions, did not show significant differences in weight in comparison to controls when the animals were treated by doses of 50, 100 and 200 mg/kg of both extracts. However, the increase in liver weight in mice treated with CAE 400 mg/kg could be attributed to a toxic effect. Liver enlargement occurs in animals and humans as a result of physiological adaptation, metabolic abnormalities, toxic effects, inflammatory processes or proliferative diseases (Williams & Iatropoulos 2002) . However, we could not positively identify a relevant toxic effect from this result since histopathological examination and/or biochemical measurements were not performed in this study.
The PFC assay is considered to be one of the most highly predictive single assays for detection of the immunomodulatory/immunotoxic potential of several substances and drugs. It was used to assess potential modulation of the humoral immune response, which quantifies the number of B cells producing SRBC-specific IgM (Wilson et al. 1999). It is considered that substances and preparations inducing PFC increases are immunostimulators (Davis & Kuttan 2000) . The increased number of PFCs in animals treated with 100 mg/kg of CAE (p < 0.05) therefore suggests the presence of immunomodulators. Previous studies in our laboratory showed similar results for A. maritima (M Uecker, unpublished observations). HAE or CAE water root extracts of the plant in 100 mg/kg doses were able to induce an increase in PFCs.
In this study, the increased anti-SRBC IgM titers four days after treatment with the three doses of CAE (p < 0.05, p < 0.01, p < 0.01, respectively) and after seven days with the lower dosage, in addition to increased IgG titers after seven days treatment, reinforces the hypothesis concerning immunomodulatory extract properties.
In contrast with our results, Guerra et al. (2003) , using the same method employed in the present study (anti-SRBC IgM-producing cells/PFC), demonstrated that the aqueous extract of A. tenella (5 mg/kg) caused a significant reduction of anti-SRBC IgM-specific cells. At a higher dose (50 mg/kg), the same extract had no effect on IgM specific response. According to these authors, this immunosupressive activity of inhibiting production of antibodies to T-dependent antigens could be concomitant with immunostimulant properties increasing production of mitogen-induced antibodies. The present study demonstrated that 100 mg/kg of CAE, administered concomitantly with the immunization with SRBC, increased the number of anti-SRBC PFCs. Doses of 50 and 200 mg/kg showed no differences in PFC numbers (Fig. 3A) . However, anti-SRBC IgM and IgG serum titers as measured by ELISA were significantly enhanced after administration of the three doses of CAE (50, 100 and 200 mg/kg) four and seven days after immunization with SRBC, respectively ( Figs 4A, B) . We can speculate that these differences between our results and those of Guerra et al. (2003) may be due to variations in mouse strain (Swiss vs. BALB/c), route of antigen administration (i.p. vs i.v.), scheme/timing of extract administration (previous vs concomitant to immunization) and sensitivity of antibody detection methods (PFC vs ELISA). In addition, such differences may be attributed to variation in the chemical composition of plants according to the geographical area and the time or season of collection. Differences in the plant parts used and extract preparation process may also explain the discrepancy in the results.
The carrageenan-induced paw edema assay, conducted to evaluate anti-inflammatory activity (Winter et al. 1962) in A. tenella extracts, is a frequently used and adequate model used since 1962 in rodents, and is believed to be biphasic. The first phase involves serotonin, histamine and kinin release followed by a second phase, which is mediated by prostaglandin and cyclooxygenase products (Vinegar et al. 1969) . In the present study, the paw edema was significantly reduced by 200 or 400 mg/ kg of CAE extract (p < 0.001) and 400 mg/kg of HAE (p < 0.001). The pattern of anti-inflammatory activity exhibited by A. tenella extracts, which is similar to that of indomethacin used as positive control in this study, tend to suggest that the plant activity may at least be partially mediated by cyclooxygenase -1 and -2 inhibition. Moraes et al. (1994) suggest that the blockade of lymphocyte proliferation by a component isolated from A. tenella may contribute to the plant anti-inflammatory properties since stimulated lymphocytes secret cytokines which attract neutrophils during the inflammatory process. The results of the paw edema assay prompt the hypothesis that CAE has components with immunosupressive activity alongside others, which could be immunostimulatory since stimulation of PFC was demonstrated. Several other plant extracts have also been shown to have simultaneous immunosupressive and immunostimulatory effects (Yamaguchi 1992 , Mediratta et al. 2002 .
The aqueous extracts of A. tenella were obtained by maceration with the same proportion of the powdered fresh plant and solvent mass (1:20 mpl/msol) at RT (27 o C) and at 50 o C, with time of extraction being 12 h and 30 min for CAE and HAE extraction, respectively (Fig. 1) . The different time in extraction can lead to different contents for the active compounds in the lyophilized aqueous extracts prepared. In addition, the CAE extract yield was 9.80 g, while the HAE yield was 4.14 g from the same mass of powdered fresh plant (250 g). The cold water can lead to the extraction of distinct compounds with the same class of secondary metabolites in comparison with hot water or at different concentrations, in spite of the increase in temperature. These facts, at least partly, can justify the difference in the biological activity observed for the extracts CAE and HAE. The difference between the extract effects could be also due to the presence of constituents not extracted or destroyed depending on the extraction process.
The initial chemical characterization of the A. tenella aqueous extracts has demonstrated the occurrence of flavonoids, tannins, glycosides and saponins. Flavonoid heterosides, like quercetin, isorhamnetin and kaempferol, could be present as aglycone. These flavonoids were previously isolated in the phytochemical studies performed with the ethanol extracts of this plant (Salvador et al. 2006) . Flavonoids have many pharmacologic properties including immunomodulatory, anti-oxidant and anti-inflammatory activities (Ielpo et al. 2000) and its presence in the extracts could explain, at least partially, the results obtained in this work.
As a whole, our results contribute to a comprehensive understanding of the plant's biological properties and provide a scientific foundation for its popular use.
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